Stephen C Woods Selected Research

apolipoprotein A-IV (apolipoprotein AIV)

10/2014	Estradiol stimulates apolipoprotein A-IV gene expression in the nucleus of the solitary tract through estrogen receptor-α.
7/2010	Estradiol increases the anorectic effect of central apolipoprotein A-IV.
9/2008	Characterization of apolipoprotein A-IV in brain areas involved in energy homeostasis.
6/2007	Hypothalamic apolipoprotein A-IV is regulated by leptin.
12/2004	Consumption of a high-fat diet alters the homeostatic regulation of energy balance.
8/2004	Obesity induced by a high-fat diet downregulates apolipoprotein A-IV gene expression in rat hypothalamus.
7/2004	Diurnal rhythm of apolipoprotein A-IV in rat hypothalamus and its relation to food intake and corticosterone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen C Woods Research Topics

Disease

74	Body Weight (Weight, Body) 01/2021 - 02/2002
69	Obesity 12/2020 - 02/2002
26	Insulin Resistance 01/2021 - 02/2002
21	Weight Loss (Weight Reduction) 01/2021 - 02/2005
13	Weight Gain 01/2019 - 02/2003
13	Hyperphagia (Overeating) 09/2013 - 08/2002
11	Glucose Intolerance 01/2021 - 02/2007
8	AIDS-Related Complex (ARC) 01/2021 - 02/2003
6	Type 2 Diabetes Mellitus (MODY) 01/2017 - 08/2009
5	Hyperglycemia 10/2015 - 08/2008
4	Inflammation (Inflammations) 01/2018 - 11/2008
4	Metabolic Diseases (Metabolic Disease) 01/2018 - 02/2011
4	Fatty Liver 07/2013 - 03/2007
3	Fistula 10/2015 - 11/2007
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2015 - 06/2010
3	Anorexia 12/2012 - 04/2005
2	Substance-Related Disorders (Drug Abuse) 08/2020 - 01/2014
2	Hypoglycemia (Reactive Hypoglycemia) 10/2015 - 09/2013
1	Nausea 01/2020
1	Gliosis 01/2018

Drug/Important Bio-Agent (IBA)

36	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2006
32	Insulin (Novolin)FDA Link 01/2021 - 02/2002
16	LeptinIBA 01/2021 - 06/2002
12	LipidsIBA 11/2017 - 01/2007
11	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2015 - 02/2005
10	Hormones (Hormone)IBA 01/2018 - 01/2005
9	MelanocortinsIBA 12/2020 - 06/2002
7	apolipoprotein A-IV (apolipoprotein AIV)IBA 10/2014 - 07/2004
7	Messenger RNA (mRNA)IBA 02/2012 - 12/2006
6	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2019 - 12/2006
6	Peptides (Polypeptides)IBA 05/2013 - 10/2009
5	Appetite Depressants (Anorectics)IBA 01/2018 - 04/2005
5	salicylhydroxamic acid (SHAM)IBA 11/2016 - 09/2010
5	RimonabantIBA 10/2011 - 03/2007
4	EnzymesIBA 01/2021 - 03/2007
4	Pharmaceutical PreparationsIBA 08/2020 - 10/2004
4	GlucocorticoidsIBA 10/2015 - 07/2004
4	Dietary Fats (Dietary Fat)IBA 05/2009 - 04/2003
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2008
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 02/2007
3	Estrogens (Estrogen)FDA Link 01/2016 - 04/2006
3	Glucagon (Glukagon)FDA Link 10/2015 - 10/2009
3	IncretinsIBA 10/2015 - 02/2011
3	Blood Glucose (Blood Sugar)IBA 09/2013 - 05/2002
3	Insulin ReceptorIBA 09/2013 - 02/2002
3	Glucagon-Like Peptide-1 ReceptorIBA 07/2013 - 08/2008
3	CholesterolIBA 05/2013 - 02/2007
3	Angiotensin IIIBA 03/2013 - 07/2010
3	Agouti-Related ProteinIBA 01/2013 - 02/2003
3	Cholecystokinin (Pancreozymin)IBA 12/2012 - 05/2010
3	GhrelinIBA 10/2012 - 04/2007
3	Estradiol (Delestrogen)FDA LinkGeneric 07/2010 - 04/2006
3	EndocannabinoidsIBA 08/2009 - 03/2007
2	celastrolIBA 03/2019 - 11/2018
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 10/2015
2	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2018 - 02/2005
2	Glial Fibrillary Acidic ProteinIBA 10/2017 - 09/2008
2	CarbohydratesIBA 01/2017 - 07/2012
2	Apolipoproteins AIBA 10/2015 - 06/2012
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 10/2015 - 09/2013
2	ginsenoside Rb1IBA 09/2015 - 05/2013
2	AMP-Activated Protein KinasesIBA 09/2015 - 05/2013
2	Sucrose (Saccharose)IBA 09/2014 - 01/2012
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2013 - 09/2009
2	Exenatide (Byetta)FDA Link 07/2013 - 10/2007
2	Bile Acids and Salts (Bile Acids)IBA 07/2013 - 09/2010
2	PalmitatesIBA 10/2012 - 05/2009
2	CytokinesIBA 06/2012 - 11/2008
2	Insulin AntibodiesIBA 01/2012 - 01/2004
2	Islet Amyloid PolypeptideIBA 08/2010 - 07/2006
2	NeuropeptidesIBA 06/2010 - 04/2007
2	Apolipoproteins E (ApoE)IBA 08/2009 - 08/2008
2	Leptin ReceptorsIBA 08/2009 - 03/2008
2	ApolipoproteinsIBA 08/2009 - 08/2008
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2008 - 07/2008
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2008 - 03/2007
2	Neuropeptide YIBA 04/2007 - 07/2004
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 08/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	trkB ReceptorIBA 10/2017
1	CeramidesIBA 10/2017
1	Dietary SugarsIBA 01/2017
1	Advanced Glycation End ProductsIBA 01/2017
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2017
1	SHU 9119IBA 10/2015
1	DEET (DET)IBA 07/2015
1	InsulinsIBA 07/2015

Therapy/Procedure

10	Therapeutics 01/2018 - 09/2003
9	Bariatric Surgery 01/2017 - 02/2005
9	Gastrectomy 11/2016 - 06/2010
7	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2014 - 01/2005
3	Fat-Restricted Diet (Diet, Fat Restricted) 11/2017 - 07/2011
2	Caloric Restriction 12/2014 - 11/2012
2	Adrenalectomy 07/2004 - 12/2003